Sweden · Series A startup

Who invested in Oncopeptides

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 31 Oct 2026

Undisclosedraised across 1 round since 2013, from 1 source

Latest round
Series AMay 2013
Investors
0
See who backed them

The rounds

  1. May 2013
    Series AAmount undisclosed

    No investor was named in the report.

    Reported by pevc.dowjones.com

Also claim to have backed them

This firm lists Oncopeptides as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

IndustrifondenVC firmPer its own site

Quick answers about Oncopeptides

How much has Oncopeptides raised?

Oncopeptides has raised 1 round since 2013, none with a disclosed amount.

When did Oncopeptides last raise?

Oncopeptides's most recent round was a Series A in May 2013.

What stage is Oncopeptides at?

Oncopeptides's latest named round is a Series A, in May 2013.

Where is Oncopeptides based?

Oncopeptides is based in Sweden.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.